title: [Pagetoid lymphoma of the Ketron-Goodman type].
authors.affiliation: Service de Dermatologie, Hôpital Henri-Mondor, Université Paris XII, Créteil.
authors.forename: P
authors.initials: P
authors.lastname: Royer
authors.forename: M
authors.initials: M
authors.lastname: Bagot
authors.forename: J
authors.initials: J
authors.lastname: Wechsler
authors.forename: J C
authors.initials: JC
authors.lastname: Roujeau
authors.forename: S
authors.initials: S
authors.lastname: Fraitag
authors.forename: J
authors.initials: J
authors.lastname: Revuz
mesh_terms: D000328:Adult; D015703:Antigens, CD / Q000276:immunology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007150:Immunohistochemistry; D008223:Lymphoma / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D010641:Phenotype; D011241:Prednisone / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology*; D013601:T-Lymphocytes / Q000473:pathology; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D015703:Antigens, CD; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
vernacular_title: Lymphome pagétoïde type Ketron-Goodman.